167 related articles for article (PubMed ID: 31482507)
21. Statin-drug interactions: not a class effect.
Frishman WH; Horn J
Cardiol Rev; 2008; 16(4):205-12. PubMed ID: 18562811
[TBL] [Abstract][Full Text] [Related]
22. Overcoming patient reluctance to statin intolerance.
Katamesh BE; Mickow AA; Huang L; Dougan BM; Ratrout BM; Nanda S; Vincent A
Kardiol Pol; 2024; 82(5):485-491. PubMed ID: 38712783
[TBL] [Abstract][Full Text] [Related]
23. Statin myopathy: the iceberg or its tip?
Campbell WW
Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
[No Abstract] [Full Text] [Related]
24. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
25. Attitudes and actions: A survey to assess statin use among Finnish patients with increased risk for cardiovascular events.
Silvennoinen R; Turunen JH; Kovanen PT; Syvänne M; Tikkanen MJ
J Clin Lipidol; 2017; 11(2):485-494. PubMed ID: 28502506
[TBL] [Abstract][Full Text] [Related]
26. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
[TBL] [Abstract][Full Text] [Related]
27. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R
Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
[TBL] [Abstract][Full Text] [Related]
28. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
29. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
[TBL] [Abstract][Full Text] [Related]
30. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
[TBL] [Abstract][Full Text] [Related]
31. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.
Cho L; Dent R; Stroes ESG; Stein EA; Sullivan D; Ruzza A; Flower A; Somaratne R; Rosenson RS
Cardiovasc Drugs Ther; 2018 Aug; 32(4):365-372. PubMed ID: 30073585
[TBL] [Abstract][Full Text] [Related]
32. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries.
Rosenson RS; Gandra SR; McKendrick J; Dent R; Wieffer H; Cheng LI; Catapano AL; Oh P; Kees Hovingh G; Stroes ES
Cardiovasc Drugs Ther; 2017 Apr; 31(2):187-195. PubMed ID: 28466399
[TBL] [Abstract][Full Text] [Related]
33. Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study.
Palmer E; Johar I; Little DJ; Karlsson N
Adv Ther; 2024 Jul; 41(7):2757-2775. PubMed ID: 38722538
[TBL] [Abstract][Full Text] [Related]
34. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report.
Okeahialam BN
Vasc Health Risk Manag; 2015; 11():579-81. PubMed ID: 26604775
[TBL] [Abstract][Full Text] [Related]
35. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy of dyslipidemias in the adult population.
Vigna GB; Fellin R
Expert Opin Pharmacother; 2010 Dec; 11(18):3041-52. PubMed ID: 20958118
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
[TBL] [Abstract][Full Text] [Related]
38. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
Ahmed ST; Akeroyd JM; Mahtta D; Street R; Slagle J; Navar AM; Stone NJ; Ballantyne CM; Petersen LA; Virani SS
J Am Heart Assoc; 2020 Nov; 9(22):e017915. PubMed ID: 33170055
[TBL] [Abstract][Full Text] [Related]
39. Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey.
Hovingh GK; Gandra SR; McKendrick J; Dent R; Wieffer H; Catapano AL; Oh P; Rosenson RS; Stroes ES
Atherosclerosis; 2016 Feb; 245():111-7. PubMed ID: 26717273
[TBL] [Abstract][Full Text] [Related]
40. "Lower abdominal pains, as if I was being squeezed…in a clamp": A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer.
Martin ML; Halling K; Eek D; Reaney M
Patient; 2020 Apr; 13(2):189-200. PubMed ID: 31691205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
